AdaptHealth (AHCO) vs Bioventus (BVS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Bioventus (BVS) has outperformed AdaptHealth (AHCO) over the past year, gaining 92.0% versus a loss of 34.8%. Over five years, BVS leads with a -6.4% price change compared with -76.7% for AHCO. Bioventus is the larger company by market cap ($858.6 million vs $805.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AHCO | BVS |
|---|---|---|
| Share price | $6.04 | $12.57 |
| Market cap | $805.12M | $858.60M |
| 1-day change | +2.64% | -1.57% |
| YTD return | -40.96% | +71.64% |
| 1-year return | -34.81% | +92.03% |
| 5-year return | -76.72% | -6.38% |
| P/E ratio (TTM) | — | 16.12 |
| Forward P/E | — | 13.66 |
| EPS (TTM) | $-1.82 | $0.78 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.43 | $15.89 |
| 52-week low | $5.21 | $6.37 |
| Distance from 52-week high | -55.06% | -20.91% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +46.81% | +40.02% |
| Average volume | 2.88M | 619.63K |
| Shares outstanding | 133.41M | 68.31M |
| Employees | 10,900 | 950 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BVS has outperformed AHCO by 126.8 percentage points over the past year.
About AdaptHealth
AHCO stock →AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments.
Health Care · Medical/Nursing Services · 10,900 employees
About Bioventus
BVS stock →Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a benchtop device that processes whole blood to produce high-yield PRP with a 10-minute single-spin cycle.
Health Care · Medical/Dental Instruments · 950 employees
AHCO vs BVS FAQ
Which is bigger, AdaptHealth or Bioventus?
Bioventus (BVS) is larger, with a market capitalization of $858.60M compared with $805.12M for AdaptHealth (AHCO).
Which stock has performed better over the past year, AHCO or BVS?
BVS returned +92.03% over the past 12 months, compared with -34.81% for AHCO (price return, excluding dividends). Past performance does not predict future results.
Are AdaptHealth and Bioventus in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Nursing Services for AdaptHealth and Medical/Dental Instruments for Bioventus.